12-week open label treatment of refractory bipolar depression (BD) with combination of Depakote ER (DEP) [valproate semisodium] and aripiprazole (AZP)
Phase of Trial: Phase IV
Latest Information Update: 20 Apr 2017
At a glance
- Drugs Aripiprazole (Primary) ; Valproate semisodium
- Indications Bipolar I disorders; Bipolar II disorders
- Focus Therapeutic Use
- 25 Aug 2006 New trial record.